Drug
PD 1 Blocking Antibody
PD 1 Blocking Antibody: highest development phase Phase 2, developed by Bristol-Myers Squibb. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Bristol-Myers Squibb
Trials
| Drug | Phase | Indication |
|---|---|---|
| PD-1 blocking antibody NCT03984357 | Phase 2 | Nasopharyngeal Carcinoma |
Latest
No recent events.
Follow PD 1 Blocking Antibody on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.